Ventricular Tachycardia Catheter Ablation: Retrospective Analysis and Prospective Outlooks-A Comprehensive Review
Laura Adina Stanciulescu1,2, Radu Vatasescu1,2
1Cardio-Thoracic Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Insights
Catheter ablation effectively treats ventricular tachycardia (VT), a dangerous heart rhythm. While standard methods work for scar-related VT, new techniques and AI show promise for complex cases, improving patient quality of life.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
Background:
- Ventricular tachycardia (VT) poses significant mortality risks, especially in patients with structural heart disease.
- Implantable cardioverter-defibrillators (ICDs) prevent sudden cardiac death but do not eliminate VT episodes or recurrent therapies, impacting quality of life.
Purpose of the Study:
- To review current catheter ablation strategies for ventricular tachycardia.
- To discuss limitations of traditional ablation techniques and explore emerging alternative methods and technologies.
Main Methods:
- Overview of percutaneous and epicardial catheter ablation approaches.
- Discussion of four primary mapping strategies: activation, entrainment, pace, and substrate mapping.
- Exploration of alternative ablation techniques including stereotactic radioablation, surgical ablation, needle ablation, and ethanol ablation.
Main Results:
- Catheter ablation is a safe and effective treatment for VT, targeting re-entry circuits.
- Traditional ablation is highly effective for scar-related VT but may be insufficient for nonischemic cardiomyopathies.
- Alternative methods show promising results, though further comparative studies are needed.
Conclusions:
- Catheter ablation is a key treatment for drug-refractory or intolerant VT patients.
- Emerging techniques and artificial intelligence hold potential for improving VT management, especially in complex cases.
- Continued research is essential to validate new methods against standard radiofrequency ablation.
Abstract:
Ventricular tachycardia is a potentially life-threatening arrhythmia associated with an overall high morbi-mortality, particularly in patients with structural heart disease. Despite their pivotal role in preventing sudden cardiac death, implantable cardioverter-defibrillators, although a guideline-based class I recommendation, are unable to prevent arrhythmic episodes and significantly alter the quality of life by delivering recurrent therapies. From open-heart surgical ablation to the currently widely used percutaneous approach, catheter ablation is a safe and effective procedure able to target the responsible re-entry myocardial circuit from both the endocardium and the epicardium. There are four main mapping strategies, activation, entrainment, pace, and substrate mapping, each of them with their own advantages and limitations. The contemporary guideline-based recommendations for VT ablation primarily apply to patients experiencing antiarrhythmic drug ineffectiveness or those intolerant to the pharmacological treatment. Although highly effective in most cases of scar-related VTs, the traditional approach may sometimes be insufficient, especially in patients with nonischemic cardiomyopathies, where circuits may be unmappable using the classic techniques. Alternative methods have been proposed, such as stereotactic arrhythmia radioablation or radiotherapy ablation, surgical ablation, needle ablation, transarterial coronary ethanol ablation, and retrograde coronary venous ethanol ablation, with promising results. Further studies are needed in order to prove the overall efficacy of these methods in comparison to standard radiofrequency delivery. Nevertheless, as the field of cardiac electrophysiology continues to evolve, it is important to acknowledge the role of artificial intelligence in both the pre-procedural planning and the intervention itself.
